EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols von Kalina, T, Flores-Montero, J, van der Velden, V H J, Martin-Ayuso, M, Böttcher, S, Ritgen, M, Almeida, J, Lhermitte, L, Asnafi, V, Mendonça, A, de Tute, R, Cullen, M, Sedek, L, Vidriales, M B, Pérez, J J, te Marvelde, J G, Mejstrikova, E, Hrusak, O, Szczepański, T, van Dongen, J J M, Orfao, A

Volltext

Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age‐related changes and disease‐induced shifts von van Lochem, E.G., van der Velden, V.H.J., Wind, H.K., te Marvelde, J.G., Westerdaal, N.A.C., van Dongen, J.J.M.

Volltext

P086 Flow cytometry in myelodysplastic syndromes: a new tool in the classification and prognostification of low/int-I risk MDS von van de Loosdrecht, A.A, Westers, T.M, Westra, A.H, Dräger, A.M, van van der Velden, V.H.J, Ossenkoppele, G.J

Volltext

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes von van Dongen, J J M, Lhermitte, L, Böttcher, S, Almeida, J, van der Velden, V H J, Flores-Montero, J, Rawstron, A, Asnafi, V, Lécrevisse, Q, Lucio, P, Mejstrikova, E, Szczepański, T, Kalina, T, de Tute, R, Brüggemann, M, Sedek, L, Cullen, M, Langerak, A W, Mendonça, A, Macintyre, E, Martin-Ayuso, M, Hrusak, O, Vidriales, M B, Orfao, A

Volltext

Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay von Dekking, E., PhD, van der Velden, V.H.J., PhD, Böttcher, S., MD, PhD, Brüggemann, M., MD, PhD, Sonneveld, E., PhD, Koning-Goedheer, A., BSc, Boeckx, N., MD, PhD, Lucio, P., MD, PhD, Sedek, L., MSc, Szczepański, T., MD, PhD, Kalina, T., PhD, Kovac, M., MSc, Evans, P., PhD, Hoogeveen, P.G., BSc, Flores-Montero, J., MD, PhD, Orfao, A., MD, PhD, Comans-Bitter, W.M., BSc, Staal, F.J.T., PhD, van Dongen, J.J.M., MD, PhD

Volltext

Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working... von Porwit, A, van de Loosdrecht, A A, Bettelheim, P, Brodersen, L Eidenschink, Burbury, K, Cremers, E, Della Porta, M G, Ireland, R, Johansson, U, Matarraz, S, Ogata, K, Orfao, A, Preijers, F, Psarra, K, Subirá, D, Valent, P, van der Velden, V H J, Wells, D, Westers, T M, Kern, W, Béné, M C

Volltext

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group von Westers, T M, Ireland, R, Kern, W, Alhan, C, Balleisen, J S, Bettelheim, P, Burbury, K, Cullen, M, Cutler, J A, Della Porta, M G, Dräger, A M, Feuillard, J, Font, P, Germing, U, Haase, D, Johansson, U, Kordasti, S, Loken, M R, Malcovati, L, te Marvelde, J G, Matarraz, S, Milne, T, Moshaver, B, Mufti, G J, Ogata, K, Orfao, A, Porwit, A, Psarra, K, Richards, S J, Subirá, D, Tindell, V, Vallespi, T, Valent, P, van der Velden, V H J, de Witte, T M, Wells, D A, Zettl, F, Béné, M C, van de Loosdrecht, A A

Volltext

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL von Kuiper, R P, Waanders, E, van der Velden, V H J, van Reijmersdal, S V, Venkatachalam, R, Scheijen, B, Sonneveld, E, van Dongen, J J M, Veerman, A J P, van Leeuwen, F N, Geurts van Kessel, A, Hoogerbrugge, P M

Volltext

Cluster analysis of genomic ETV6 – RUNX1 ( TEL – AML1 ) fusion sites in childhood acute lymphoblastic leukemia von von Goessel, H, Jacobs, U, Semper, S, Krumbholz, M, Langer, T, Keller, T, Schrauder, A, van der Velden, V.H.J, van Dongen, J.J.M, Harbott, J, Panzer-Grümayer, E.R, Schrappe, M, Rascher, W, Metzler, M

Volltext

Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia von Denys, B, van der Sluijs-Gelling, A J, Homburg, C, van der Schoot, C E, de Haas, V, Philippé, J, Pieters, R, van Dongen, J J M, van der Velden, V H J

Volltext

Highly sensitive MRD tests for ALL based on the IKZF1 Δ3–6 microdeletion von Venn, N C, van der Velden, V H J, de Bie, M, Waanders, E, Giles, J E, Law, T, Kuiper, R P, de Haas, V, Mullighan, C G, Haber, M, Marshall, G M, MD, Norris, van Dongen, J J M, Sutton, R

Volltext

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia von Waanders, E, van der Velden, V H J, van der Schoot, C E, van Leeuwen, F N, van Reijmersdal, S V, de Haas, V, Veerman, A J, van Kessel, A Geurts, Hoogerbrugge, P M, Kuiper, R P, van Dongen, J J M

Volltext

Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol von Stutterheim, J., de Lorenzo, P., van der Sluis, I.M., Alten, J., Ancliffe, P., Attarbaschi, A., Aversa, L., Boer, J.M., Biondi, A., Brethon, B., Diaz, P., Cazzaniga, G., Escherich, G., Ferster, A., Kotecha, R.S., Lausen, B., Leung, Alex WK, Locatelli, F., Silverman, L., Stary, J., Szczepanski, T., van der Velden, V.H.J., Vora, A., Zuna, J., Schrappe, M., Valsecchi, M.G., Pieters, R.

Volltext

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97 MRC AML12 protocol von van der Velden, V H J, van der Sluijs-Geling, A, Gibson, B E S, te Marvelde, J G, Hoogeveen, P G, Hop, W C J, Wheatley, K, Bierings, M B, Schuurhuis, G J, de Graaf, S S N, van Wering, E R, van Dongen, J J M

Volltext

Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia von Schotte, D, Chau, J C K, Sylvester, G, Liu, G, Chen, C, van der Velden, V H J, Broekhuis, M J C, Peters, T C J M, Pieters, R, Boer, M L den

Volltext

The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells von de Vries, J F, Zwaan, C M, De Bie, M, Voerman, J S A, den Boer, M L, van Dongen, J J M, van der Velden, V H J

Volltext

Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol von Van der Velden, V H J, Corral, L, Valsecchi, M G, Jansen, M W J C, De Lorenzo, P, Cazzaniga, G, Panzer-Grümayer, E R, Schrappe, M, Schrauder, A, Meyer, C, Marschalek, R, Nigro, L L, Metzler, M, Basso, G, Mann, G, Den Boer, M L, Biondi, A, Pieters, R, Van Dongen, J J M

Volltext

Extensive longitudinal immune profiling reveals sustained innate immune activaton in COVID-19 patients with unfavorable outcome von Schrijver, B, Assmann, J.L.J.C, van Gammeren, A.J, Vermeulen, R.C.H, Portengen, L, Heukels, P, Langerak, A.W, Dik, W.A, van der Velden, V.H.J, Ermens, T.A.A.M

Volltext

Telomere length and telomerase complex mutations in pediatric acute myeloid leukemia von Aalbers, A M, Calado, R T, Young, N S, Zwaan, C M, Wu, C, Kajigaya, S, Coenen, E A, Baruchel, A, Geleijns, K, de Haas, V, Kaspers, G J L, Kuijpers, T W, Reinhardt, D, Trka, J, Zimmermann, M, Pieters, R, van der Velden, V H J, van den Heuvel-Eibrink, M M

Volltext

Flow cytometry diagnosis in myelodysplastic syndrome: Current practice in Latin America and comparison with other regions of the world von Grille, S., Iastrebner, M., Lorand-Metze, I., van der Velden, V.H.J., Ikoma, M.R.V., Vidal-Senmache, G., Colado, E., Rabelo-Carrasco, L.J., Blanco, A., Huamán-Garaicoa, F., O’Connor, J.E., Cao Pochintesta, C., Jensen, E., Bacal, N.S., Díaz, L., Lens, D.

Volltext